Rolvedon (Eflapegrastim-xnst)
- Medicine Name: Rolvedon
- Generic Name: Eflapegrastim-xnst
- Dosage Form & Strength: Injection: 13.2 mg/0.6 mL solution
- Manufactured By: Spectrum Pharmaceuticals, Inc.
Rolvedon (eflapegrastim-xnst) is a leukocyte growth factor used to reduce the incidence of infection, as manifested by febrile neutropenia, in adults with non-myeloid malignancies receiving myelosuppressive anti-cancer therapeutic drugs linked with a clinically significant incidence of febrile neutropenia.
Limitations of Use: Rolvedon 13.2 mg/0.6 mL is not for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.
Recommended Dosage: The recommended dosage of Rolvedon is a single subcutaneous (SC) injection of 13.2 mg given once per chemotherapy cycle. Administer around 24 hours after cytotoxic chemotherapy. Avoid administering within the period from 2 weeks before to 24 hours after the use of cytotoxic chemo.
- Splenic rupture can occur after the use of rhG-CSF products, such as Rolvedon injection. Evaluate for an enlarged spleen or splenic rupture in those who report left upper abdominal or shoulder pain after taking treatment with Rolvedon.
- Acute respiratory distress syndrome (ARDS) can occur in those receiving rhG-CSF products, such as Rolvedon. Assess those who develop fever and lung infiltrates or respiratory distress after the use of Rolvedon for ARDS. Discontinue treatment in those with ARDS.
- Critical allergic reactions, including anaphylaxis, may develop in those taking rhG-CSF products. Permanently discontinue this medicine in patients with severe allergic reactions. Do not use this medicine in those with a history of severe allergic reactions to pegfilgrastim, eflapegrastim, or filgrastim products.
- Serious and sometimes fatal sickle cell crises may occur in those with sickle cell disorders taking Rolvedon. Discontinue treatment with Rolvedon in case a sickle cell crisis occurs.
- White blood cell counts of 100 x 109 /L or higher have been noticed in those receiving rhG-CSF products. Monitor complete blood count (CBC) during therapy. Discontinue treatment if a WBC count of 100 x 109 /L or higher occurs.
- Thrombocytopenia has been observed in patients receiving treatment with rhG-CSF products. It is advised to monitor platelet counts.
- AML and MDS have been associated with the use of Rolvedon in conjunction with chemo and/or radiotherapy in those with lung and breast cancer. Monitor patients for signs and symptoms of AML/MDS in these settings.
What documents are required to import ROLVEDON to India?
ROLVEDON (eflapegrastim-xnst) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
Is ROLVEDON available in India?
ROLVEDON (eflapegrastim-xnst injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Rolvedon in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
ROLVEDON can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of ROLVEDON (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Rolvedon 13.2 mg/0.6 mL price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Rolvedon®?
Eflapegrastim-xnst is a Generic Name for the trade name drug Rolvedon®.
What is the Manufacturer’s Name of Rolvedon®?
Rolvedon® is manufactured by Spectrum Pharmaceuticals, Inc.
Is Rolvedon® approved by the FDA?
Yes, Rolvedon® is approved by the FDA. Date of approval: September 9, 2022.
Where can I get Rolvedon® at the best price in India?
To get the best Rolvedon price in India, kindly connect with the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Rolvedon®, a valid medical prescription is needed from a treating physician.
What is the dosage and form of Rolvedon® supplied?
Rolvedon® is supplied as Injections: 13.2 mg/0.6 mL solution in a single-dose prefilled syringe for subcutaneous administration.
What are the most common side effects of Rolvedon®?
The most common side effects of Rolvedon® are headache, fatigue, nausea, diarrhea, bone pain, pyrexia, rash, anemia, myalgia, back pain, and arthralgia.
How much does Rolvedon® cost in India?
The cost of Rolvedon in India can vary. In order to procure this therapeutic drug legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Rolvedon®?
Store refrigerated at 36-46°F (2-8°C) in the carton to protect from light. Avoid shaking. Avoid freezing; discard the syringe in case frozen.
Is it safe to buy Rolvedon® online in India?
Yes, one can buy Rolvedon online in India at the lowest price from the Indian Pharma Network (IPN) if the medicine Rolvedon® is not (yet) registered or available in their country. We can help facilitate the supply of Rolvedon® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.